| What it does | Evidence-based CBT techniques for tinnitus relief
| Pathology AI platform for precision medicine from discovery through diagnosis
|
|---|
| Stage | Startup
| Established
|
|---|
| Founded | 2025
| 2014
|
|---|
| Based in | US
| US
|
|---|
| Pricing model | Freemium
| Contact for pricing
|
|---|
| Pricing | Free trial for first 3 days, then one-time purchase for lifetime access to full 6-week program
| Not given
|
|---|
| Key features | - CBT techniques including thought restructuring and attention redirection
- Validated assessment tool for progress tracking across 6-week program
- Relaxation techniques and sleep hygiene practices
- Structured 6-week educational program
- Content developed by board-certified neurotologist with medical oversight
- Available on iOS and Android platforms
- Lifetime access after one-time purchase
- Audio lessons and guided exercises
| - Intelligent case review with microscope feel and AI integration
- Automated worklist prioritization and routing
- AI-powered stain panel and ancillary test recommendations
- Integrated image analysis scoring for PD-L1, HER2, Ki-67
- Real-time specialist co-review and collaboration
- Automated structured report generation
- Automatic storage tiering and cost optimization
- Integration with Epic Beaker and LIS systems
- HIPAA-compliant cloud platform with SOC 2 Type II certification
|
|---|
| What makes it different | - Grounded in evidence from 28 randomized trials showing CBT reduces tinnitus distress
- Created by a board-certified neurotologist specializing in tinnitus management
- One-time purchase with lifetime access, no recurring subscription
- Free trial for first 3 days with no credit card required
- Digital CBT delivery with evidence from randomized trials
| - FDA-cleared for primary clinical diagnosis with Concentriq AP-Dx
- Highest-rated digital pathology platform by KLAS in US and Europe
- Pathologists prefer Concentriq to the microscope
- Storage costs reduction of approximately 51% through automatic tiering
- 100% of customers told KLAS they would buy Concentriq again
|
| Community votes | 0 | 0 |
| DR (Domain Rating by Ahrefs) | 7 ● no change since last check | 61 ● no change since last check |
| Trust Flow (Majestic) | 0 | 16 |
| Citation Flow (Majestic) | 16 | 39 |
| Referring domains (Majestic) | 3 | 670 |